IBDEI3D4 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,56523,0)
 ;;=N47.7^^259^2819^17
 ;;^UTILITY(U,$J,358.3,56523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56523,1,3,0)
 ;;=3^Prepuce inflammatory diseases,Other
 ;;^UTILITY(U,$J,358.3,56523,1,4,0)
 ;;=4^N47.7
 ;;^UTILITY(U,$J,358.3,56523,2)
 ;;=^5015729
 ;;^UTILITY(U,$J,358.3,56524,0)
 ;;=N48.1^^259^2819^2
 ;;^UTILITY(U,$J,358.3,56524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56524,1,3,0)
 ;;=3^Balanitis
 ;;^UTILITY(U,$J,358.3,56524,1,4,0)
 ;;=4^N48.1
 ;;^UTILITY(U,$J,358.3,56524,2)
 ;;=^12525
 ;;^UTILITY(U,$J,358.3,56525,0)
 ;;=N47.6^^259^2819^3
 ;;^UTILITY(U,$J,358.3,56525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56525,1,3,0)
 ;;=3^Balanoposthitis
 ;;^UTILITY(U,$J,358.3,56525,1,4,0)
 ;;=4^N47.6
 ;;^UTILITY(U,$J,358.3,56525,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,56526,0)
 ;;=N48.30^^259^2819^20
 ;;^UTILITY(U,$J,358.3,56526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56526,1,3,0)
 ;;=3^Priapism, Unspec
 ;;^UTILITY(U,$J,358.3,56526,1,4,0)
 ;;=4^N48.30
 ;;^UTILITY(U,$J,358.3,56526,2)
 ;;=^5015733
 ;;^UTILITY(U,$J,358.3,56527,0)
 ;;=N48.32^^259^2819^18
 ;;^UTILITY(U,$J,358.3,56527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56527,1,3,0)
 ;;=3^Priapism d/t disease classified elsewhere
 ;;^UTILITY(U,$J,358.3,56527,1,4,0)
 ;;=4^N48.32
 ;;^UTILITY(U,$J,358.3,56527,2)
 ;;=^5015735
 ;;^UTILITY(U,$J,358.3,56528,0)
 ;;=N48.33^^259^2819^21
 ;;^UTILITY(U,$J,358.3,56528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56528,1,3,0)
 ;;=3^Priapism, drug-induced
 ;;^UTILITY(U,$J,358.3,56528,1,4,0)
 ;;=4^N48.33
 ;;^UTILITY(U,$J,358.3,56528,2)
 ;;=^5015736
 ;;^UTILITY(U,$J,358.3,56529,0)
 ;;=N48.39^^259^2819^19
 ;;^UTILITY(U,$J,358.3,56529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56529,1,3,0)
 ;;=3^Priapism, Other
 ;;^UTILITY(U,$J,358.3,56529,1,4,0)
 ;;=4^N48.39
 ;;^UTILITY(U,$J,358.3,56529,2)
 ;;=^5015737
 ;;^UTILITY(U,$J,358.3,56530,0)
 ;;=N50.1^^259^2819^23
 ;;^UTILITY(U,$J,358.3,56530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56530,1,3,0)
 ;;=3^Vascular disorders male genital organs
 ;;^UTILITY(U,$J,358.3,56530,1,4,0)
 ;;=4^N50.1
 ;;^UTILITY(U,$J,358.3,56530,2)
 ;;=^125508
 ;;^UTILITY(U,$J,358.3,56531,0)
 ;;=N52.9^^259^2819^8
 ;;^UTILITY(U,$J,358.3,56531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56531,1,3,0)
 ;;=3^Male erectile dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,56531,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,56531,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,56532,0)
 ;;=N52.39^^259^2819^15
 ;;^UTILITY(U,$J,358.3,56532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56532,1,3,0)
 ;;=3^Post-surg erectile dysfunction,Other
 ;;^UTILITY(U,$J,358.3,56532,1,4,0)
 ;;=4^N52.39
 ;;^UTILITY(U,$J,358.3,56532,2)
 ;;=^5015761
 ;;^UTILITY(U,$J,358.3,56533,0)
 ;;=N53.9^^259^2819^10
 ;;^UTILITY(U,$J,358.3,56533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56533,1,3,0)
 ;;=3^Male sexual dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,56533,1,4,0)
 ;;=4^N53.9
 ;;^UTILITY(U,$J,358.3,56533,2)
 ;;=^5015769
 ;;^UTILITY(U,$J,358.3,56534,0)
 ;;=N53.12^^259^2819^12
 ;;^UTILITY(U,$J,358.3,56534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56534,1,3,0)
 ;;=3^Painful ejaculation
 ;;^UTILITY(U,$J,358.3,56534,1,4,0)
 ;;=4^N53.12
 ;;^UTILITY(U,$J,358.3,56534,2)
 ;;=^5015765
 ;;^UTILITY(U,$J,358.3,56535,0)
 ;;=N53.8^^259^2819^9
 ;;^UTILITY(U,$J,358.3,56535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56535,1,3,0)
 ;;=3^Male sexual dysfunction,Other
 ;;^UTILITY(U,$J,358.3,56535,1,4,0)
 ;;=4^N53.8
 ;;^UTILITY(U,$J,358.3,56535,2)
 ;;=^5015768
 ;;^UTILITY(U,$J,358.3,56536,0)
 ;;=N44.1^^259^2819^6
 ;;^UTILITY(U,$J,358.3,56536,1,0)
 ;;=^358.31IA^4^2
